Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

WellSpring’s $3M Equipment Purchase & New Partnership

By Andy Szal | April 8, 2016

WellSpring Pharma Services on Thursday announced millions in new equipment purchases and a strategic partnership to produce drugs for the U.S. market.

The Canadian pharmaceutical contract manufacturer said that its $3 million capital investment would provide new expertise in production for early clinical trials and, in the future, enable expansion of its large-scale manufacturing.

In particular, it will provide scalable development capabilities, expanded production of specialized dosage forms — such as bilayer tablets — and support for high-potency compound manufacturing.
 

“We’re now better equipped to offer our clients services from small-scale development and scale-up to large-scale manufacturing, packaging and distribution,” company president David Mayers said in a statement.

The new equipment includes an Alexanderwerk Roller Compactor, an IMA Precisa capsule weight checker, an O’Hara Tray Drying oven and Aqueous Film Coater, a Korsch XL 400 Tablet Press, a Glatt GPCG 2/5 Fluid Bed Processor and a 5L Becomix Counter sweep vessel.

WellSpring will detail the capital expansion and new branding at the annual INTERPHEX trade show later this month.

In addition, the company announced a partnership with IDT Australia to produce several products at WellSpring’s facility near Toronto. The agreement includes the cardiac drug Pindolol, which Wellspring valued at $10 million on the U.S. market.

IDT is aiming to establish itself as a specialty generics business and is commercializing 24 drugs for sale via U.S. distributors.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

GSK
GSK invests another $800M in Pennsylvania site expansions
This is a BD image of its major IV catheters manufacturing facility in Sandy, Utah, which the company said produces billions of molded components each year.
BD to invest billions in U.S. manufacturing
Diverse factory workers in yellow PPE suits checking production data with clipboard in modern industrial facility, Quality control inspector wearing masks and hairnets working in food or pharma plant
ISO 9001, 14001 and 45001 revisions: What changes and when to start
Artis BioSolutions announces new center of excellence in Spain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE